ntu.edu.tw Objective To measure the effects of faecal immunochemical test (FIT) for colorectal cancer (CRC) screening on overall and site-specific long-term effectiveness of population-based organised ...

Quest to Support Mainz Biomed’s ReconAAsense FDA Study and Has Option to Commercialize Test Kit Assuming FDA ApprovalBERKELEY ...

Lowering the positivity threshold for a high-quality fecal immunochemical test (FIT) can increase sensitivity of noninvasive screening for colorectal cancer in a more economical way.

Abu Dhabi health chiefs have hailed the introduction of a blood test for colon cancer as a "game-changer" in the emirate's ...

50 million Americans due for colon cancer screening avoid it because they consider traditional tests so unpleasant. But now it can be as simple as a blood test. If you’re overdue for your ...

Mainz Biomed’s stool-based ColoAlert test is designed to detect colorectal cancer tumor DNA ... Force recommends that screening with stool DNA-FIT (sDNA-FIT) tests should be conducted once ...

Its research also concludes that African Americans have the highest rates of colorectal cancer when compared to any racial/ethnic group in the US. The FDA recently approved Guardant Health’s “Shield” ...